These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32251416)

  • 1. Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis.
    Masuda H; Mori M; Uzawa A; Uchida T; Ohtani R; Kuwabara S
    PLoS One; 2020; 15(4):e0224419. PubMed ID: 32251416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Modified Fatigue Impact Scale and the relationships among fatigue, pain and serum interleukin-6 levels in patients with neuromyelitis optica spectrum disorder.
    Masuda H; Mori M; Uzawa A; Uchida T; Ohtani R; Kobayashi S; Kuwabara S
    J Neurol Sci; 2018 Feb; 385():64-68. PubMed ID: 29406915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Nakamura Y; Liu Z; Fukumoto S; Shinoda K; Sakoda A; Matsushita T; Hayashida S; Isobe N; Watanabe M; Hiwatashi A; Yamasaki R; Kira JI
    Eur J Neurol; 2020 Jan; 27(1):92-99. PubMed ID: 31304648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging Differences between Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis: A Multi-Institutional Study in Japan.
    Tatekawa H; Sakamoto S; Hori M; Kaichi Y; Kunimatsu A; Akazawa K; Miyasaka T; Oba H; Okubo T; Hasuo K; Yamada K; Taoka T; Doishita S; Shimono T; Miki Y
    AJNR Am J Neuroradiol; 2018 Jul; 39(7):1239-1247. PubMed ID: 29724765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Lee CY; Mak HK; Chiu PW; Chang HC; Barkhof F; Chan KH
    J Magn Reson Imaging; 2018 Jun; 47(6):1601-1609. PubMed ID: 28990252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics in multiple sclerosis and neuromyelitis optica spectrum disorder.
    Liu Y; Dong D; Zhang L; Zang Y; Duan Y; Qiu X; Huang J; Dong H; Barkhof F; Hu C; Fang M; Tian J; Li K
    Eur Radiol; 2019 Sep; 29(9):4670-4677. PubMed ID: 30770971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population.
    Silveira F; Pappolla A; Sánchez F; Marques VD; de Castillo IS; Tkachuk V; Caride A; Castillo MC; Cristiano E; Cruz CA; Diégues Serva GB; Dos Santos AC; Moreira CL; López PA; Patrucco L; Molina O; Pettinicchi JP; Carnero Contentti E; Rojas JI
    Mult Scler Relat Disord; 2020 Jul; 42():102049. PubMed ID: 32251869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patients.
    Carnero Contentti E; Marques VD; Soto de Castillo I; Tkachuk V; Barreira AA; Caride A; Castillo MC; Cristiano E; de Aquino Cruz C; Braga Diégues Serva G; Santos ACD; Labarca R; Lavigne Moreira C; López PA; Miguez J; Molina O; Pettinicchi JP; Rojas JI
    Mult Scler; 2020 Jul; 26(8):945-954. PubMed ID: 31124748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cord myelin water imaging shows degenerative changes over one year in multiple sclerosis but not neuromyelitis optica spectrum disorder.
    Combes AJE; Matthews L; Lee JS; Li DKB; Carruthers R; Traboulsee AL; Barker GJ; Palace J; Kolind S
    Neuroimage Clin; 2017; 16():17-22. PubMed ID: 28725551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. χ-Separation Imaging for Diagnosis of Multiple Sclerosis versus Neuromyelitis Optica Spectrum Disorder.
    Kim W; Shin HG; Lee H; Park D; Kang J; Nam Y; Lee J; Jang J
    Radiology; 2023 Apr; 307(1):e220941. PubMed ID: 36413128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
    Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
    Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint radiomics and spatial distribution model for MRI-based discrimination of multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin-oligodendrocyte-glycoprotein-IgG-associated disorder.
    Luo X; Li H; Xia W; Quan C; ZhangBao J; Tan H; Wang N; Bao Y; Geng D; Li Y; Yang L
    Eur Radiol; 2024 Jul; 34(7):4364-4375. PubMed ID: 38127076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Jeong IH; Choi JY; Kim SH; Hyun JW; Joung A; Lee J; Kim HJ
    Mult Scler; 2016 Oct; 22(12):1616-1620. PubMed ID: 26920375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
    Masuda H; Mori M; Hirano S; Uzawa A; Uchida T; Muto M; Ohtani R; Aoki R; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):32-40. PubMed ID: 34362853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating multiple sclerosis and neuromyelitis optica spectrum disorders through pontine trigeminal nerve lesions: A comparative MRI study.
    Kojita Y; Kono AK; Yamada T; Yamada M; Im SW; Kozuka T; Kaida H; Kuwahara M; Nagai Y; Ishii K
    Eur J Radiol; 2024 Sep; 178():111597. PubMed ID: 38996736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized estimates of morphometric similarity in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Sun J; Zhao W; Xie Y; Zhou F; Wu L; Li Y; Li H; Li Y; Zeng C; Han X; Liu Y; Zhang N
    Neuroimage Clin; 2023; 39():103454. PubMed ID: 37343344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients.
    Liao MF; Chang KH; Lyu RK; Huang CC; Chang HS; Wu YR; Chen CM; Chu CC; Kuo HC; Ro LS
    BMC Neurol; 2014 Nov; 14():218. PubMed ID: 25433369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS.
    Liu Y; Duan Y; Huang J; Ren Z; Liu Z; Dong H; Weiler F; Hahn HK; Shi FD; Butzkueven H; Barkhof F; Li K
    Eur Radiol; 2018 Jan; 28(1):96-103. PubMed ID: 28667482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis.
    Mariano R; Messina S; Roca-Fernandez A; Leite MI; Kong Y; Palace JA
    Brain; 2021 Feb; 144(1):198-212. PubMed ID: 33206944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Callosal lesions on magnetic resonance imaging with multiple sclerosis, neuromyelitis optica spectrum disorder and acute disseminated encephalomyelitis.
    Cai MT; Zhang YX; Zheng Y; Fang W; Ding MP
    Mult Scler Relat Disord; 2019 Jul; 32():41-45. PubMed ID: 31030018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.